3Gastiasoro-Cuesta E, Alvarez-Diaz FJ, Rey-Santano C, et al. Acute and sustained effects of lucinactant versus poractant-alpha on pulmonary gas exchange and mechanics in premature lambs with respiratory distress syndrome. Pediatrics, 2006,117(2) :295-303.
4Janssen DJ, Carnielli VP, Cogo P, et al. Surfactant phosphatidylcholine metabolism in neonates with meconium aspiration syndrome. J Pediatr, 2006,149(5) :634-639.
5Chinese Collaborative Study Group for Neontal Neonatal Respiratory Diseases. Treatment of severe meconium aspiration syndrome with porcine suffactant: A multicentre, randomized, controlled trial. Acta Paediatr, 2005,94 ( 7 ) : 896-902.
6Hilgendorff A, Rawer D, Doemer M, et al. Synthetic and natural surfactant differentially modulate inflammation after meconium aspiration. Intensive Care Med, 2003,29 ( 12 ) : 2247-2254.
7Lyra JC, Mascaretti RS, Precioso AR, et al. Different doses of exogenous surfactant for treatment of mecomum aspiration syndrome in newborn rabbits. Rev Hosp Clin Fac Med Sao Paulo, 2004,59(3 ) : 104-112.
8Dargaville PA, Mills JF, Copnell B, et al. Therapeutic lung lavage in meconium aspiration syndrome: A preliminary report. J Paediatr Child Health, 2007,43 (7-8) :539-545.
9Szymonkiewicz M, Godzinowski J, Kowalska K. Pulmonary function after suffactant lung lavage followed by surfactsnt administraction in infants with severe meconium aspiration syndrome. J Matern fetal Neonatal Med, 2004, 16(2) : 125-130.
10Dargaville PA, Mills JF. Surfactant therapy for meconium aspiration current status. Drugs,2005,65(18) :2569-2591.
